Literature DB >> 26113425

Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice.

Camilo Jimenez1, Steven G Waguespack.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26113425     DOI： 10.1007/s12020-015-0672-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

Review 1.  The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.

Authors:  Juan P Brito; Noor Asi; Michael R Gionfriddo; Catalina Norman; Aaron L Leppin; Claudia Zeballos-Palacios; Chaitanya Undavalli; Zhen Wang; Juan P Domecq; Gabriela Prustsky; Tarig A Elraiyah; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2015-02-06       Impact factor: 3.633

2.  Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.

Authors:  Montserrat Ayala-Ramirez; J Lynn Palmer; Marie-Claude Hofmann; Maxine de la Cruz; Bryan S Moon; Steven G Waguespack; Mouhammed Amir Habra; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

Review 3.  Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

Authors:  Patricia L M Dahia
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

4.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Marcella M Johnson; Shamim Ejaz; Mouhammed Amir Habra; Thereasa Rich; Naifa Busaidy; Gilbert J Cote; Nancy Perrier; Alexandria Phan; Shreyaskumar Patel; Steven Waguespack; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

5.  Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.

Authors:  C Lepoutre-Lussey; C Caramella; F Bidault; D Déandreis; A Berdelou; A Al Ghuzlan; D Hartl; I Borget; A-P Gimenez-Roqueplo; F Dumont; F Deschamps; C Nascimento; J Lumbroso; M Guillaud Bataille; M Schlumberger; E Baudin; S Leboulleux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-13       Impact factor: 9.236

6.  Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

Authors:  Montserrat Ayala-Ramirez; Cecile N Chougnet; Mouhammed Amir Habra; J Lynn Palmer; Sophie Leboulleux; Maria E Cabanillas; Caroline Caramella; Pete Anderson; Abir Al Ghuzlan; Steven G Waguespack; Desirée Deandreis; Eric Baudin; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2012-09-10       Impact factor: 5.958

Review 7.  Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

Authors:  Eric Baudin; Mouhammed Amir Habra; Frederic Deschamps; Gilbert Cote; Frederic Dumont; Maria Cabanillas; J Arfi-Roufe; A Berdelou; Bryan Moon; Abir Al Ghuzlan; Shreyaskumar Patel; Sophie Leboulleux; Camilo Jimenez
Journal:  Eur J Endocrinol       Date:  2014-06-02       Impact factor: 6.664

8.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

9.  Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Anna Kozupa; Clara C Chen; Jorge A Carrasquillo; Alexander Ling; Graeme Eisenhofer; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Oncol       Date:  2007-06-01       Impact factor: 44.544

10.  Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.

Authors:  Kory W Jasperson; Wendy Kohlmann; Amanda Gammon; Heidi Slack; Luke Buchmann; Jason Hunt; Anne C Kirchhoff; Henry Baskin; Akram Shaaban; Joshua D Schiffman
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375
  10 in total
  1 in total

Review 1.  Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review.

Authors:  Yanliang Yang; Guangzhi Wang; Haofeng Lu; Yaqing Liu; Shili Ning; Fuwen Luo
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.